WATERTOWN, Mass. — A new bleeding control method that uses injectable foam is generating a lot of interest, in particular from the Pentagon, which hopes to use it to treat injured soldiers.

The new injectable form is expected to be more convenient for patients and could help shield the company from erosion of sales when the patent for the intravenous version expires later this decade.